Development and validation of an optimized prediction of mortality for candidates awaiting liver transplantation

被引:84
作者
Bertsimas, Dimitris [1 ]
Kung, Jerry [1 ]
Trichakis, Nikolaos [1 ]
Wang, Yuchen [1 ]
Hirose, Ryutaro [2 ]
Vagefi, Parsia A. [3 ]
机构
[1] MIT, Operat Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA
关键词
ethics and public policy; liver transplantation; hepatology; auxiliary; simulation; statistics; HEPATOCELLULAR-CARCINOMA; MELD; ALLOCATION; DELTA; MODEL;
D O I
10.1111/ajt.15172
中图分类号
R61 [外科手术学];
学科分类号
摘要
Since 2002, the Model for End-Stage Liver Disease (MELD) has been used to rank liver transplant candidates. However, despite numerous revisions, MELD allocation still does not allow for equitable access to all waitlisted candidates. An optimized prediction of mortality (OPOM) was developed () utilizing machine-learning optimal classification tree models trained to predict a candidate's 3-month waitlist mortality or removal utilizing the Standard Transplant Analysis and Research (STAR) dataset. The Liver Simulated Allocation Model (LSAM) was then used to compare OPOM to MELD-based allocation. Out-of-sample area under the curve (AUC) was also calculated for candidate groups of increasing disease severity. OPOM allocation, when compared to MELD, reduced mortality on average by 417.96 (406.8-428.4) deaths every year in LSAM analysis. Improved survival was noted across all candidate demographics, diagnoses, and geographic regions. OPOM delivered a substantially higher AUC across all disease severity groups. OPOM more accurately and objectively prioritizes candidates for liver transplantation based on disease severity, allowing for more equitable allocation of livers with a resultant significant number of additional lives saved every year. These data demonstrate the potential of machine learning technology to help guide clinical practice, and potentially guide national policy.
引用
收藏
页码:1109 / 1118
页数:10
相关论文
共 50 条
  • [31] Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis on intention-to-treat outcomes
    Di Martino, Marcello
    Ferraro, Daniele
    Pisaniello, Donatella
    Arenga, Giuseppe
    Falaschi, Federica
    Terrone, Alfonso
    Maniscalco, Marilisa
    Lanza, Alfonso Galeota
    Esposito, Ciro
    Vennarecci, Giovanni
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (04) : 429 - 438
  • [32] Subjective parameters markedly limit the referral of transplantation candidates to liver transplant centres
    Vidal-Trecan, Gwenaelle
    Kone, Victoria
    Pilette, Christophe
    Nousbaum, Jean-Baptiste
    Doll, Jacques
    Buffet, Catherine
    Eugene, Claude
    Podevin, Philippe
    Boutet, Olivier
    Puyeo, Jacques
    Conti, Filomena
    Calmus, Yvon
    LIVER INTERNATIONAL, 2016, 36 (04) : 555 - 562
  • [33] External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    van Hooff, Maria C.
    Sonneveld, Milan J.
    Ijzermans, Jan N.
    Doukas, Michail
    Sprengers, Dave
    Metselaar, Herold J.
    den Hoed, Caroline M.
    de Man, Robert A.
    CANCERS, 2022, 14 (03)
  • [34] Development and validation of a model for early survival prediction following liver transplantation based on donor and recipient characteristics
    Xie, Zhonghao
    Lin, Xiaohong
    Wang, Yan
    Chen, Zhitao
    Zeng, Ping
    He, Xiaoshun
    Ju, Weiqiang
    Chen, Maogen
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [35] Optimism and coping styles: A comparison of candidates for liver transplantation with candidates for lung transplantation
    Stilley, CS
    Miller, DJ
    Manzetti, JD
    Marino, IR
    Keenan, RJ
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 1999, 68 (06) : 299 - 303
  • [36] Moderate Ascites Identifies Patients With Low Model for End-Stage Liver Disease Scores Awaiting Liver Transplantation Who Have a High Mortality Risk
    Somsouk, Ma
    Kornfield, Rachel
    Vittinghoff, Eric
    Inadomi, John M.
    Biggins, Scott W.
    LIVER TRANSPLANTATION, 2011, 17 (02) : 129 - 136
  • [37] Palliative Care in End-Stage Liver Disease Patients Awaiting Liver Transplantation: Review
    Silva, Sara Vieira
    Freire, Elga
    Miranda, Helena Pessegueiro
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2020, 27 (06) : 417 - 428
  • [38] Outcome of patients with acute liver failure awaiting liver transplantation in Japan
    Genda, Takuya
    Ichida, Takafumi
    Sakisaka, Shotaro
    Tanaka, Eiji
    Mochida, Satoshi
    Ueno, Yoshiyuki
    Inui, Ayano
    Egawa, Hiroto
    Umeshita, Koji
    Furukawa, Hiroyuki
    Kawasaki, Seiji
    Inomata, Yukihiro
    HEPATOLOGY RESEARCH, 2020, 50 (10) : 1186 - 1195
  • [39] Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States
    Young, Kellie
    Liu, Benny
    Bhuket, Taft
    Gish, Robert G.
    Wong, Robert J.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (03) : 350 - 361
  • [40] Diagnosis of tuberculosis infection in patients awaiting liver transplantation
    Lindemann, Monika
    Dioury, Youness
    Beckebaum, Susanne
    Cicinnati, Vito R.
    Gerken, Guido
    Broelsch, Christoph E.
    Wrighton-Smith, Peter
    Grosse-Wilde, Hans
    HUMAN IMMUNOLOGY, 2009, 70 (01) : 24 - 28